KPTI - Karyopharm Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $39.39. This is a potential upside of $35.19 (837.86%) from yesterday's end of day stock price of $4.2.

Karyopharm Therapeutics's activity chart (see below) currently has 15 price targets and 14 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.4% with an average time for these price targets to be met of 85.82 days.

Highest price target for KPTI is $56, Lowest price target is $56, average price target is $30.

Most recent stock forecast was given by EDWARD WHITE from HC WAINWRIGHT on 02-Mar-2025. First documented stock forecast 02-Jun-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$56

$49.99 (831.78%)

$7

2 months 28 days ago
(02-Mar-2025)

1/2 (50%)

$44.41 (383.18%)

12

Hold

$4

$2.69 (205.34%)

$10

1 years 9 months 23 days ago
(07-Aug-2023)

6/11 (54.55%)

$2.39 (148.45%)

305

Hold

$5

$3.69 (281.68%)

$6

2 years 4 months 20 days ago
(10-Jan-2023)

3/7 (42.86%)

$2.13 (74.22%)

225

Buy

$14

$12.69 (968.70%)

$22

2 years 9 months 25 days ago
(05-Aug-2022)

0/5 (0%)

$9.32 (199.15%)

Hold

$8

$6.69 (510.69%)

3 years 3 months 21 days ago
(09-Feb-2022)

6/6 (100%)

$-1.06 (-11.70%)

85

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KPTI (Karyopharm Therapeutics) average time for price targets to be met?

On average it took 85.82 days on average for the stock forecasts to be realized with a an average price target met ratio 33.4

Which analyst has the current highest performing score on KPTI (Karyopharm Therapeutics) with a proven track record?

MICHAEL ULZ

Which analyst has the most public recommendations on KPTI (Karyopharm Therapeutics)?

Michael Ulz works at BAIRD and has 9 price targets and 6 ratings on KPTI

Which analyst is the currently most bullish on KPTI (Karyopharm Therapeutics)?

Arlinda Lee with highest potential upside - $126.15

Which analyst is the currently most reserved on KPTI (Karyopharm Therapeutics)?

Brian Abrahams with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?